The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immunoscore as a parameter predicting time to recurrence and disease-free survival in T4N0 stage II colon cancer patients.
 
Jerome Galon
Stock and Other Ownership Interests - HalioDx
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Catalym; Gilead Sciences; Gilead Sciences; GlaxoSmithKline; Northwest Biotherapeutics; Roche; Sanofi
Research Funding - AstraZeneca; ImageIQ; IO Biotech; Janssen; MedImmune; Perkin Elmer
Patents, Royalties, Other Intellectual Property - Patent holder: INSERM
 
Fabienne Hermitte
Employment - HalioDx
Leadership - HalioDx
Stock and Other Ownership Interests - HalioDx
 
Bernhard Mlecnik
Patents, Royalties, Other Intellectual Property - INSERM
 
Alessandro Lugli
Honoraria - 3DHISTECH; Sakura Finetek Japan; Sysmex
Consulting or Advisory Role - Amgen
 
Carlo Bruno Bifulco
Stock and Other Ownership Interests - PrimeVax
Consulting or Advisory Role - Bristol-Myers Squibb; PrimeVax
Patents, Royalties, Other Intellectual Property - PROVIDENCE HEALTH & SERVICES
 
Iris D. Nagtegaal
No Relationships to Disclose
 
Arndt Hartmann
Honoraria - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; MSD; Roche
Consulting or Advisory Role - 3DHISTECH; AstraZeneca; Bristol-Myers Squibb; Cepheid; Diaceutics; Illumina; Ipsen; Janssen-Cilag; MSD; NanoString Technologies; Qiagen; Roche
Research Funding - AstraZeneca; BioNTech; Cepheid; Janssen-Cilag; NanoString Technologies; Roche
Expert Testimony - NanoString Technologies
 
Florence Marliot
Travel, Accommodations, Expenses - HalioDx
 
Marc Van Den Eynde
Honoraria - HalioDx
 
Michael H. A. Roehrl
Honoraria - Gerson Lehrman Group
Consulting or Advisory Role - Proscia; Trans-Hit Bio; UDX
 
Pamela S Ohashi
No Relationships to Disclose
 
Eva Zavadova
No Relationships to Disclose
 
Toshihiko Torigoe
No Relationships to Disclose
 
Prabhudas S. Patel
No Relationships to Disclose
 
Yili Wang
No Relationships to Disclose
 
Yutaka Kawakami
Honoraria - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; MSD; Ono Pharmaceutical; Sumitomo Group
Consulting or Advisory Role - Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb; Ono Pharmaceutical
 
Francesco Marincola
Employment - Abbvie
Leadership - Abbvie
 
Paolo Antonio Ascierto
Stock and Other Ownership Interests - PrimeVax
Consulting or Advisory Role - 4SC; Alkermes; Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Genmab; Idera; Immunocore; Incyte; Italfarmaco; MedImmune; Merck Serono; Merck Sharp & Dohme; Nektar; Newlink Genetics; Novartis; Pierre Fabre; Roche/Genentech; Sandoz; Sanofi; Sun Pharma; Syndax; Ultimovacs
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Bernard A. Fox
Employment - UbiVac; UbiVac (I)
Leadership - UbiVac
Stock and Other Ownership Interests - PrimeVax; UbiVac
Honoraria - Janssen Biotech; Nodality
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Celldex; Definiens; Incyte; Macrogenics; MedImmune; OncoSec; Turnstone Bio; Ultivue
Research Funding - Akoya Biosciences; Bristol-Myers Squibb; DEfiniens; Janssen Biotech; Macrogenics (Inst); MedImmune (Inst); Merck; NanoString Technologies; OncoSec; Perkin Elmer; Shimadzu; Viralytics
Patents, Royalties, Other Intellectual Property - Patent around the DPV-001 cancer vaccine. This patent is owned by the Providence Health System and licensed to UbiVac
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Definiens; Definiens; NanoString Technologies
 
Franck Pages
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Janssen; Merck; Roche
Research Funding - Bristol-Myers Squibb; HalioDx
Patents, Royalties, Other Intellectual Property - INSERM
Travel, Accommodations, Expenses - HalioDx